Cargando…

Acceptance Rate of Influenza Vaccination Among Patients with Type II Diabetes

BACKGROUND: It is well known that patients with diabetes are at increased risk of influenza infection and its serious complications. Our aim was to evaluate the attitude towards and prevalence of influenza vaccination among Saudi patients with diabetes. METHODOLOGY: Descriptive questionnaire-based c...

Descripción completa

Detalles Bibliográficos
Autor principal: Alsufyani, Shahad Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930144/
https://www.ncbi.nlm.nih.gov/pubmed/35309605
http://dx.doi.org/10.4103/jfmpc.jfmpc_115_21
_version_ 1784670997236940800
author Alsufyani, Shahad Ali
author_facet Alsufyani, Shahad Ali
author_sort Alsufyani, Shahad Ali
collection PubMed
description BACKGROUND: It is well known that patients with diabetes are at increased risk of influenza infection and its serious complications. Our aim was to evaluate the attitude towards and prevalence of influenza vaccination among Saudi patients with diabetes. METHODOLOGY: Descriptive questionnaire-based cross-sectional survey of a sample of patients with diabetes attending a specialist diabetic centre in the Ministry of Health Hospital in Taif city in Saudi Arabia. We utilized a generalized logistic regression model analysis to evaluate the effect of background factors on influenza vaccine uptake. RESULTS: The study included (n = 336) patients with diabetes. The prevalence of uptake of influenza vaccine was 43.5% (CI: 38.2% to 48.8%). Adjusted analysis of background effects revealed that uptake of influenza vaccine was improved with age, university education, and belief in the dangerousness of flu infection in patients with diabetes. Factors that deterred from the uptake of flu vaccines were longer in DM duration, getting health messages about flu vaccines, belief in vaccine effectiveness, health practitioner information, in addition to physician recommendation of the vaccine. CONCLUSION: The content of health messages about flu vaccine and the quality of practitioner-patient interaction requires considerable improvement and re-evaluation if the flu vaccine uptake rates among Saudi individuals with diabetes were to increase. Comprehensive therapeutic packages for patients with diabetes should include high quality education about influenza vaccine. Research into preventative measures among patients with diabetes should evaluate the effect of educational interventions using robust methodology.
format Online
Article
Text
id pubmed-8930144
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-89301442022-03-18 Acceptance Rate of Influenza Vaccination Among Patients with Type II Diabetes Alsufyani, Shahad Ali J Family Med Prim Care Original Article BACKGROUND: It is well known that patients with diabetes are at increased risk of influenza infection and its serious complications. Our aim was to evaluate the attitude towards and prevalence of influenza vaccination among Saudi patients with diabetes. METHODOLOGY: Descriptive questionnaire-based cross-sectional survey of a sample of patients with diabetes attending a specialist diabetic centre in the Ministry of Health Hospital in Taif city in Saudi Arabia. We utilized a generalized logistic regression model analysis to evaluate the effect of background factors on influenza vaccine uptake. RESULTS: The study included (n = 336) patients with diabetes. The prevalence of uptake of influenza vaccine was 43.5% (CI: 38.2% to 48.8%). Adjusted analysis of background effects revealed that uptake of influenza vaccine was improved with age, university education, and belief in the dangerousness of flu infection in patients with diabetes. Factors that deterred from the uptake of flu vaccines were longer in DM duration, getting health messages about flu vaccines, belief in vaccine effectiveness, health practitioner information, in addition to physician recommendation of the vaccine. CONCLUSION: The content of health messages about flu vaccine and the quality of practitioner-patient interaction requires considerable improvement and re-evaluation if the flu vaccine uptake rates among Saudi individuals with diabetes were to increase. Comprehensive therapeutic packages for patients with diabetes should include high quality education about influenza vaccine. Research into preventative measures among patients with diabetes should evaluate the effect of educational interventions using robust methodology. Wolters Kluwer - Medknow 2022-01 2022-01-31 /pmc/articles/PMC8930144/ /pubmed/35309605 http://dx.doi.org/10.4103/jfmpc.jfmpc_115_21 Text en Copyright: © 2022 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Alsufyani, Shahad Ali
Acceptance Rate of Influenza Vaccination Among Patients with Type II Diabetes
title Acceptance Rate of Influenza Vaccination Among Patients with Type II Diabetes
title_full Acceptance Rate of Influenza Vaccination Among Patients with Type II Diabetes
title_fullStr Acceptance Rate of Influenza Vaccination Among Patients with Type II Diabetes
title_full_unstemmed Acceptance Rate of Influenza Vaccination Among Patients with Type II Diabetes
title_short Acceptance Rate of Influenza Vaccination Among Patients with Type II Diabetes
title_sort acceptance rate of influenza vaccination among patients with type ii diabetes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930144/
https://www.ncbi.nlm.nih.gov/pubmed/35309605
http://dx.doi.org/10.4103/jfmpc.jfmpc_115_21
work_keys_str_mv AT alsufyanishahadali acceptancerateofinfluenzavaccinationamongpatientswithtypeiidiabetes